Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.02 | -19.34 |
PEG Ratio (TTM) | 0.00 | -6.10 |
P/S Ratio (TTM) | 2.79 | 45.38 |
P/B Ratio (TTM) | 0.02 | 29.05 |
P/FCF Ratio (TTM) | -0.67 | -3.91 |
Price to 5YR AVG Earnings Ratio | N/A | -6.78 |
Price to 5YR AVG FCF Ratio | N/A | -12.87 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -83.34% | -15.27% |
ROE (TTM) | -126.11% | 26.93% |
Net Profit Margin (TTM) | -2,758.66% | -648.73% |
ROIC 5YR AVG | N/A | -8.24% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -19.13% | -157.47% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -22.78% | -170.71% | N/A |
Cash Flow | -30.63% | -151.12% | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.06 | 5.58 |
Quick Ratio (TTM) | 0.05 | 5.36 |
D/E Ratio (TTM) | 0.29 | 0.98 |
Interest Coverage (TTM) | -18.73 | -6.85 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | N/A | 12.49 |
LTL to 5YR AVG FCF | N/A | 0.08 |
Shares Outstanding Growth 5YR AVG | N/A | 37.38% |